Pharma Journalist -

Filament Health Corp. a clinical-stage natural psychedelic drug development company, and Psyence Group Inc, a life science biotechnology company pioneering the use of natural psilocybin…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has entered into a multi target R&D collaboration agreement with PrecisionLife Limited, a global techbio company generating the…
Read More...

Exicure, Inc. an early-stage biotechnology company historically focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets, announced the…
Read More...

SAE Media Group reports: Conference co-chairs invite delegates to join the anticipated 6th Annual 3D Cell Culture Conference SAE Media Group is delighted to announce the return of…
Read More...

Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune,…
Read More...

Harrow, an eyecare pharmaceutical company exclusively focused on the discovery, development, and commercialization of innovative ophthalmic therapies, announced that it has entered into…
Read More...

Fresenius Kabi, a global health care company that specializes in pharmaceuticals, medical technologies, and nutrition products for critical and chronic conditions, announced today that…
Read More...

UCB and Praxis Precision Medicines announced a strategic collaboration, based upon Praxis’ PRAX-020 program, for the discovery of small molecule therapeutics as potential treatments of…
Read More...

Biosion USA, Inc. announced an exploratory research collaboration to create antibody-drug conjugates (ADCs) for the treatment of cancer with ImmunoGen. In the joint research effort,…
Read More...

The European Commission (EC) granted a conditional marketing authorization for Boehringer Ingelheim’s spesolimab as first in class treatment for GPP flares in adults. Spesolimab is a…
Read More...